Pyridorin

Shares of NephroGenex Inc (NASDAQ: NRX), a nano-cap pharmaceutical company that focuses on treatment for kidney diseases, plunged more than 40 percent on Wednesday after the company announced a business update. NephroGenex said it will pause a clinical program of its product candidate oral...